Biblio
Export 1398 results:
Author Title [ Type
Filters: First Letter Of Last Name is P [Clear All Filters]
“Relationship Between Weight-Change Patterns and Cognitive Function: A Retrospective Study.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1085-1095, 2022.
, “The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 3, pp. 903-912, 2017.
, “Relation of a Socioeconomic Index with Cognitive Function and Neuroimaging in Hypertensive Individuals.”, J Alzheimers Dis, vol. 82, no. 2, pp. 815-826, 2021.
, “Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers.”, J Alzheimers Dis, vol. 94, no. 2, pp. 483-489, 2023.
, “Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1385-1405, 2020.
, “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
, “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
, “Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1119-1126, 2017.
, “Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.”, J Alzheimers Dis, vol. 59, no. 1, pp. 131-139, 2017.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 899-910, 2018.
, “Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.”, J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.
, “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
, “Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”, J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
, “Rapidly Progressive Alzheimer's Disease in Two Distinct Autopsy Cohorts.”, J Alzheimers Dis, vol. 64, no. 3, pp. 973-980, 2018.
, “Rapidly Progressive Alzheimer's Disease: Contributions to Clinical-Pathological Definition and Diagnosis.”, J Alzheimers Dis, 2018.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.
, “Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.”, J Alzheimers Dis, vol. 59, no. 2, pp. 527-536, 2017.
, “Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.”, J Alzheimers Dis, vol. 57, no. 2, pp. 575-601, 2017.
, “Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 1, pp. 157-165, 2018.
, “Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.”, J Alzheimers Dis, vol. 64, no. 2, pp. 393-404, 2018.
, “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
, “Quantifying and Examining Reserve in Symptomatic Former National Football League Players.”, J Alzheimers Dis, vol. 85, no. 2, pp. 675-689, 2021.
, “Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1027-1040, 2018.
, “Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress.”, J Alzheimers Dis, vol. 68, no. 3, pp. 885-923, 2019.
,